|Articles|June 15, 2003
- BioPharm International-06-01-2003
- Volume 16
- Issue 6
Sialylation Levels Influence Oligosaccharide Quantitation: Analyzing Response Variability Using High-pH Anion-Exchange Chromatography and Pulsed Amperometric Detection
by Chandrashekar Ganesa, Genzyme Corporation, Brian W. Granda, and Robert J. Mattaliano
Advertisement
Articles in this issue
over 22 years ago
SOX in the Boardroom: What the Sarbanes?Oxley Act Means to Youover 22 years ago
Inside Washington: Reshaping Biotech Drug Developmentover 22 years ago
BioTrends: M&A MalaiseNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
